Clinical Trial Update: Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)

View source ↗

Summary

NuVasive reports the completion of a clinical trial evaluating Osteocel Plus, a bone graft substitute, in anterior lumbar interbody fusion for lumbar degenerati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Disc Disease

Drugs mentioned

• Osteocel Plus

Snippet

Sponsor: NuVasive | Conditions: Degenerative Disc Disease, Lumbar | Status: COMPLETED